International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Welcome from the President

Dear Colleagues,

It is my honour to serve as President for the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for the term 2017-2019, following in the footsteps of numerous excellent Presidents.

Let me first mention that I very much appreciate the support from the IATDMCT membership, in allowing me to be the President of this society, for the next two years. The trust in me is a valuable thing, and my first goal is to not disappoint the membership.

Our society has grown over the years thanks to the pioneering work of laboratory scientists, chemists, clinical pharmacologists and pharmacists. Techniques to quantify drugs and metabolites in blood and other matrixes have been developed and introduced in the laboratories serving clinical centres. Increasingly our community is involved in translating the concentration measurements into a meaningful advice for the clinician. In order to further develop this interaction it is important that more medical doctors are involved in our projects. Furthermore, there is an increasing demand to provide evidence that our recommendations lead to improved outcome. To be able to conduct sufficiently powered studies that provide such high level evidence the prescribers need to be part of our team. I will do all I can to involve the MDs.       

The scientific committees form the core of our Association. In 2015 the TDM in Oncology Committee has started, and in 2017 the Toxicology and Environmental Health Committee was founded. In the scientific committees experts in various fields can meet.

The Membership of the IATDMCT spans the globe. As of December 2017 we have members from 73 countries. This represents many different cultures and people, but we all share a common goal: to improve therapeutic management of patients and the practice of medicine worldwide. IATDMCT will be offering new ways to encourage development of educational activities, whether that be through presenting recorded educational content, live webcast, webinars or travelling lectures. We hope that this will provide our younger members and members in developing countries access to educational content who may not otherwise be able to travel to meetings.

Therapeutic Drug Monitoring, the journal of our association will be undergoing several changes over the next few years, which we hope will improve not only the visibility of our field of study but our Association as well.

van Gelder 150x200

My predecessor Loralie Langman, the IATDMCT President from 2015 to 2017 used the important statement “We may be separated by geography but we are united by science.”

I look forward to meeting all of you at future IATDMCT Congresses.

Teun van Gelder 
IATDMCT President, 2017-2019